Literature DB >> 22889463

Hepatocyte transplantation using the domino concept in a child with tetrabiopterin nonresponsive phenylketonuria.

X Stéphenne1, F G Debray, F Smets, N Jazouli, G Sana, T Tondreau, R Menten, P Goffette, F Boemer, R Schoos, S W Gersting, M Najimi, A C Muntau, P Goyens, E M Sokal.   

Abstract

Phenylketonuria is a metabolic disease caused by phenylalanine hydroxylase deficiency. Treatment is based on a strict natural protein-restricted diet that is associated with the risk of malnutrition and severe psychosocial burden. Oral administration of tetrahydrobiopterin can increase residual enzyme activity, but most patients with severe clinical phenotypes are nonresponders. We performed liver cell transplantation in a 6-year-old boy with severe tetrahydrobiopterin nonresponsive phenylketonuria who failed to comply with diet prescriptions. The transplanted hepatocytes were obtained in part from an explanted glycogen storage type 1b liver. Following two infusions, blood phenylalanine levels returned within the therapeutic target while the phenylalanine half-life assessed by loading tests decreased from 43 to 19 h. However, 3 months later, blood phenylalanine concentrations increased and the phenylalanine intake had to be reduced. Cell-based therapy is a promising therapeutic option in phenylketonuria, and the domino concept may solve the issue of cell sources for hepatocyte transplantation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22889463     DOI: 10.3727/096368912X653255

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  19 in total

Review 1.  Recent advances in liver transplantation for metabolic disease.

Authors:  P J Mc Kiernan
Journal:  J Inherit Metab Dis       Date:  2017-02-06       Impact factor: 4.982

Review 2.  Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic Defects.

Authors:  Mustapha Najimi; Florence Defresne; Etienne M Sokal
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

Review 3.  Cell-based liver therapies: past, present and future.

Authors:  Valeria Iansante; Anil Chandrashekran; Anil Dhawan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

4.  Hepatocyte Transplantation in Special Populations: Clinical Use in Children.

Authors:  Zahida Khan; Stephen C Strom
Journal:  Methods Mol Biol       Date:  2017

5.  Host conditioning and rejection monitoring in hepatocyte transplantation in humans.

Authors:  Kyle A Soltys; Kentaro Setoyama; Edgar N Tafaleng; Alejandro Soto Gutiérrez; Jason Fong; Ken Fukumitsu; Taichiro Nishikawa; Masaki Nagaya; Rachel Sada; Kimberly Haberman; Roberto Gramignoli; Kenneth Dorko; Veysel Tahan; Alexandra Dreyzin; Kevin Baskin; John J Crowley; Mubina A Quader; Melvin Deutsch; Chethan Ashokkumar; Benjamin L Shneider; Robert H Squires; Sarangarajan Ranganathan; Miguel Reyes-Mugica; Steven F Dobrowolski; George Mazariegos; Rajavel Elango; Donna B Stolz; Stephen C Strom; Gerard Vockley; Jayanta Roy-Chowdhury; Marilia Cascalho; Chandan Guha; Rakesh Sindhi; Jeffrey L Platt; Ira J Fox
Journal:  J Hepatol       Date:  2016-12-24       Impact factor: 25.083

6.  Hereditary tyrosinemia type Ⅰ: newborn screening, diagnosis and treatment.

Authors:  Yue Tang; Yuanyuan Kong
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

Review 7.  Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects.

Authors:  Kara R Vogel; Andrew A Kennedy; Luke A Whitehouse; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2013-10-02       Impact factor: 4.982

8.  New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants.

Authors:  Roberto Gramignoli; Veysel Tahan; Kenneth Dorko; Kristen J Skvorak; Marc C Hansel; Wenchen Zhao; Raman Venkataramanan; Ewa C S Ellis; Carl Jorns; Bo-Goran Ericzon; Staffan Rosenborg; Raoul Kuiper; Kyle A Soltys; George V Mazariegos; Ira J Fox; Elizabeth M Wilson; Markus Grompe; Stephen C Strom
Journal:  Stem Cell Res       Date:  2013-03-27       Impact factor: 2.020

9.  Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders.

Authors:  Jochen Meyburg; Thomas Opladen; Ute Spiekerkötter; Andrea Schlune; Jens-Peter Schenk; Jan Schmidt; Jürgen Weitz; Jürgen Okun; Friederike Bürger; Tawfeg Ben Omran; Ghassan Abdoh; Hilal Al Rifai; Ahmad Monavari; Vassiliki Konstantopoulou; Stefan Kölker; Marc Yudkoff; Georg F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2017-10-12       Impact factor: 4.982

Review 10.  Human hepatocyte transplantation for liver disease: current status and future perspectives.

Authors:  V Iansante; R R Mitry; C Filippi; E Fitzpatrick; A Dhawan
Journal:  Pediatr Res       Date:  2017-12-06       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.